Skip to main content
. 2020 Jun 23;105(2):173–184. doi: 10.1111/ejh.13424

TABLE 1.

Summary table of studies selected for data extraction

First author (year)Citation Study purpose Source population
Population‐based prevalence study
Carey (2000) 7 To estimate the prevalence of PK deficiency in a general, white population Former Northern Health Region of the United Kingdom
de Medicis (1992) 8 To estimate the prevalence of PK deficiency associated with hemolytic anemia in Quebec Quebec, Canada
Molecular PKLR screening study in a general population
Beutler (2000) 10 To estimate the prevalence of PK deficiency in a general, predominately white population 3785 anonymous individuals without PK deficiency in the USA, predominately white; 20 patients with PK deficiency, mostly white Americans
Chami (2016) 16 To identify pleiotropic genetic mutations associated with RBC traits Up to 130 273 individuals in 24 discovery cohorts and five ancestries: European, African American, Hispanic, East Asian, and South Asian ancestries
Figueroa (2018) 14 To evaluate whether genetic mutations in kinases affect Tenofovir's efficacy in the treatment/prevention of HIV 505 individuals in HIV prevention trials in Thailand, the USA, and South Africa
Manco (2001) 12 To determine the frequency of allele 1456C‐T in a general population in Portugal 616 unrelated Portuguese individuals
Svidnicki (2018) 13 To evaluate PKLR mutations among Brazilian patients with PK deficiency and healthy individuals 500 healthy Brazilian blood donors
Molecular PKLR screening study in areas with endemic malaria
Alves (2010) 18 To evaluate the associations between malaria and sickle cell disease, G6PD, and PK deficiency 257 unrelated samples (selected from 1056 total samples) from Santiago Island, Ecuador
Berghout (2012) 19 To evaluate the frequency of PKLR mutations to address whether PKLR mutations are protective in malaria‐pressured areas 387 unrelated individuals, primarily from African and Asian origin
Machado (2010) 17 To evaluate possible associations between PKLR variants and malaria 396 individuals, 316 from Africa (including malaria‐infected and uninfected children) and 80 from Portugal
Machado (2012) 20 To determine PK deficiency prevalence in sub‐Saharan Africa, to evaluate PKLR variant frequency, and to evaluate the PK deficiency‐malaria association 611 individuals in sub‐Saharan Africa for gene frequency analysis, 296 for enzyme assays
Non‐molecular PK deficiency screening study in a general population
Feng (1993) 32 To establish a reference interval of PK activity and to determine PK deficiency prevalence in local Chinese population 497 healthy men and 100 neonates in China
Fox (1969) 33 To evaluate two different screening methods for erythrocyte enzyme deficiencies 1000 blood samples from individuals in a general hospital in the USA
Fung (1969) 31 To determine the incidence of PK deficiency and G6PD deficiency in the Chinese newborn in Hong Kong and the possible relation of PK deficiency with neonatal jaundice 700 consecutive neonates in Hong Kong
Garcia (1979) 28 To estimate prevalence of enzyme deficiencies including PK deficiency in a Spanish population 1636 hematologically normal individuals in Spain
Mohrenweiser (1981) 34 To evaluate the frequency of genetic variants resulting in total or near total loss of enzyme activity for nine human erythrocyte enzymes 675 neonates and 200 of their parents in the USA (697 total assayed for PK deficiency)
Mohrenweiser (1987) 35 To estimate the frequency of enzyme deficiency variants including PK deficiency 2020 unrelated neonates in the USA
Tanaka (1971) 30 To offer a thorough description of PK diagnosis and epidemiology 146 normal individuals in the USA
Tsang (1993) 27 To evaluate a new PK enzyme activity assay 193 healthy adults in Hong Kong
Wu (1985) 29 To estimate the prevalence of PK deficiency in a Chinese population of clinically normal neonates 1159 random clinically normal infants from China
Non‐molecular PK deficiency screening study in areas with endemic malaria
El‐Hazmi (1986) 36 To estimate PK deficiency and hexokinase deficiency in a population with a high frequency of G6PD deficiency 3120 individuals in outpatient clinics in Saudi Arabia
Munyanganizi (2006) 37 To determine the prevalence of hemoglobin variants including PK deficiency in Rwanda 987 neonates in Rwanda
Upadhye (2018) 38 To estimate the prevalence of hemoglobinopathies and enzyme deficiencies in India 2400 neonates in India
Non‐molecular PK deficiency screening study in areas with high consanguinity
Abu‐Melha (1991) 44 To explore the prevalence of PK deficiency in Saudis 513 clinically normal neonates in Saudi Arabia
Akin (1997) 41 To explore the prevalence of PK deficiency in a Turkish population 1190 unrelated individuals from Turkey
Al‐Naama (1994) 42 To explore erythrocyte activities including PK deficiency in Iraq 1226 clinically normal neonates and 498 healthy students in Iraq (n = 1724 total)
Al‐Naama (1995) 43 To estimate red blood cell enzyme deficiencies including PK deficiency in a population with high G6PD deficiency prevalence 506 clinically normal neonates and 343 healthy adults (n = 849 total)
Christensen (2010) 9 To report on neonates with PK deficiency, encourage clinicians to consider PK deficiency diagnosis, and discuss PK deficiency in a polygamous community 153 830 neonates screened for jaundice in the USA
Yavarian (2008) 40 To estimate PK deficiency prevalence in a south Iranian population 4017 randomly selected individuals from Iran
Non‐molecular PK deficiency screening in other unique population
Mohrenweiser (1984) 45 To evaluate the prevalence of rare electrophoretic mobility variants including PK deficiency among Native Americans Approximately 10% of 629 Native Americans
Satoh (1983) 46 To explore enzyme activity including PK in children of parents exposed to atomic bomb radiation in Japan 3069 children of individuals exposed to atomic bomb radiation in Japan
Satoh (1985) 47 To explore the frequency of inherited variations in enzyme thermostability including PK within a population of children of atomic bomb survivors 974 children of individuals exposed to atomic bomb radiation in Japan
Molecular PKLR screening in other unique population
Lyon (2011) 22 To explore the hypothesis that rare family specific genetics may account for the remaining missing heritability of ADHD A family of 4 of whom 3 have ADHD
Robinson (2010) 21 To explore the hypothesis that rare family specific genetics may account for the remaining missing heritability of ADHD A family of 4 of whom 3 have ADHD

Abbreviations: ADHD, attention‐deficit hyperactivity disorder; G6PD, glucose‐6‐phosphate dehydrogenase; HIV, human immunodeficiency virus; PK deficiency, pyruvate kinase deficiency; PK, pyruvate kinase; RBC, red blood cell; USA, United States of America.